How should Bell's palsy be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bell's Palsy Management

For adults and adolescents ≥16 years with new-onset Bell's palsy, prescribe oral corticosteroids within 72 hours of symptom onset—this is the single most important intervention that significantly improves facial nerve recovery. 11

Pharmacologic Treatment

Corticosteroids (Mandatory)

  • Initiate within 72 hours of symptom onset for maximum benefit
  • Dosing regimens (either is acceptable):
    • Prednisolone 50 mg daily for 10 days, OR
    • Prednisone 60 mg daily for 5 days, then taper over 5 days 11
  • Evidence: High-quality RCTs demonstrate 83% recovery at 3 months with steroids vs 63.6% with placebo (P<.001), and 94.4% vs 81.6% recovery at 9 months 1
  • Treatment after 72 hours has unclear benefit 1

Antiviral Therapy (Optional)

  • Do NOT use antivirals alone—they are no better than placebo 11
  • May offer antivirals (valacyclovir or acyclovir) in addition to steroids within 72 hours, particularly for:
    • Severe/complete paralysis at presentation
    • Shared decision-making with patients who understand the uncertain benefit 11
  • Evidence shows equilibrium of benefit and harm; large trials failed to prove significant benefit, though a small effect cannot be excluded 1

Pediatric Considerations

  • Evidence for steroids in children is lacking—no controlled trials exist 11
  • Children have higher spontaneous recovery rates than adults
  • May consider steroids with significant caregiver involvement in decision-making, given similar disease process to adults 1

Eye Protection (Mandatory)

Implement aggressive eye care immediately for any patient with incomplete eye closure to prevent corneal abrasions, exposure keratitis, and ulcerations 11

  • Daytime: Frequent lubricating drops
  • Nighttime: Ophthalmic ointments (provide longer protection but blur vision)
  • Additional measures: Eye taping/patching at night, moisture chambers, sunglasses
  • Monitor for: Burning, itching, irritation, vision changes, pain 1
  • Consider botulinum toxin or surgical options for persistent lagophthalmos 1

Diagnostic Approach

What TO Do:

  • History and physical examination to exclude other causes:
    • Stroke (central vs peripheral pattern)
    • Tumors (parotid, temporal bone, cerebellopontine angle)
    • Ramsay Hunt syndrome (vesicles in ear canal/palate)
    • Lyme disease (endemic areas, tick exposure)
    • Trauma, sarcoidosis 11
  • Confirm rapid onset <72 hours and unilateral presentation 11

What NOT To Do:

  • Do NOT order routine laboratory tests 1
  • Do NOT perform routine imaging (CT/MRI) unless atypical features present 1
  • Do NOT perform electrodiagnostic testing (EMG/ENoG) in incomplete paralysis 11
  • May offer electrodiagnostic testing only in complete paralysis for prognostic information 1

Common Pitfall: Recent data shows imaging use increased from 32.9% to 41.0% after guideline publication despite being explicitly discouraged—this represents unnecessary cost and radiation exposure 2

Follow-Up and Referral

Reassess or refer to facial nerve specialist if: 1

  1. New or worsening neurologic findings at any point (suggests alternative diagnosis)
  2. Ocular symptoms develop at any point (risk of corneal damage)
  3. Incomplete facial recovery at 3 months (may need advanced interventions)

Treatment Adherence Reality

Real-world data reveals significant gaps: only 51.9% of patients receive guideline-recommended steroid therapy 3, and only 33.8% receive steroids within the critical 72-hour window 2. Emergency medicine clinicians show better adherence than other specialties 4. The key message: early recognition and immediate steroid initiation within 72 hours is critical and often missed.

Treatments Without Recommendation

No recommendation can be made for: 11

  • Surgical decompression
  • Acupuncture
  • Physical therapy
  • Electrotherapy

These lack well-designed studies and high-quality evidence 56

Special Populations

  • Diabetes: Consider screening for diabetes in Bell's palsy patients, as diabetes (aOR 1.63) and diabetic complications are independently associated with Bell's palsy 7
  • Pregnancy: Treat on individualized basis; higher risk population 8
  • Contraindications to steroids: Diabetes, morbid obesity, previous steroid intolerance require individualized assessment 1

References

Guideline

clinical practice guideline: bell's palsy.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013

Research

Nationwide Adherence to Bell's Palsy Clinical Practice Guidelines: Retrospective Analysis Using a Large-Scale EHR Database.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026

Research

Adherence to Clinical Practice Guidelines for Treatment of Bell's Palsy.

WMJ : official publication of the State Medical Society of Wisconsin, 2022

Research

A general practice approach to Bell's palsy.

Australian family physician, 2016

Research

Bell's Palsy in 11,255 Cases: Cardiometabolic Associations in a Population-Based Healthcare Database.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026

Guideline

clinical practice guideline: bell's palsy executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.